Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down – Here’s What Happened

Posted by Doug Wharley on Apr 2nd, 2025

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report) shares gapped down before the market opened on Wednesday . The stock had previously closed at $16.71, but opened at $16.09. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $16.09, with a volume of 4,499 shares changing hands.

Wall Street Analysts Forecast Growth

TLX has been the subject of a number of research analyst reports. UBS Group lifted their price objective on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a report on Monday, January 27th. William Blair reiterated an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research report on Wednesday, March 12th.

View Our Latest Analysis on TLX

Telix Pharmaceuticals Limited American Depositary Shares Price Performance

The company has a 50-day moving average of $17.92.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

(Get Free Report)

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.